medigraphic.com
SPANISH

Dermatología Cosmética, Médica y Quirúrgica

Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2020, Number 4

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2020; 18 (4)

Eosinophilic Pustular Folliculitis (Ofuji’s Disease): First Case Reported in El Salvador

Martínez CE, Carpio SO, Carpio MC
Full text How to cite this article

Language: Spanish
References: 16
Page: 263-267
PDF size: 679.19 Kb.


Key words:

eosinophilic pustular folliculitis, Ofuji’s disease, papules and/or sterile pustules.

ABSTRACT

Ofuji’s disease is a rare dermatosis of unknown etiology characterized by pruritic and sterile papules and pustules which appear mainly in face and trunk. Peripheral eosinophilia can be present, and there are no systemic symptoms in immunocompetent patients. Differential diagnoses include inflammatory and eosinophilic dermatosis. Histopathology is key for diagnosis and the first line treatment is indomethacin. We present a 34-year-old Salvadorian male (immunocompetent) with history of one year of recurrent lesions and multiple treatments.


REFERENCES

  1. Nervi S, Schwartz A y Dmochowski M, Eosinophilic pustular folliculitis: a 40 year retrospect, J Am Acad Dermatol 2006; 55(2):285-9.

  2. Brito FF, Martelli AC, Cavalcante ML, Pinto AC, Itimura G y Soares CT, Ofuji disease: a rare dermatosis and its challenging therapeutic approach, An Bras Dermatol 2016; 91(5):646-8.

  3. Rodríguez-Díaz ML, Junquera D, Nosti D, Barrio L, Prado A y Martínez Merino, Foliculitis pustulosa eosinofílica (enfermedad de Ofuji): respuesta al interferón alfa 2b, Actas Dermosifiliogr 2001; 92:233-8.

  4. Steffen C, Eosinophilic pustular folliculitis (Ofuji’s disease) with response to dapsone therapy, Arch Dermatol 1985; 121:921-3.

  5. Nomura T, Katoh M, Yamamoto Y, Kabashima K y Miyachi Y, Eosinophilic pustular folliculitis: the transition in sex differences and interracial characteristics between 1965 and 2013, J Dermatol 2015; 42:343-52.

  6. Mizukawa Y y Shiohara T, Eosinophilic pustular folliculitis induced after prolonged treatment with systemic corticosteroids in a patient with pustulosis palmoplantaris, Acta Derm Venereol 1998; 78(3):221-2.

  7. García-Patos V, Pujol RM y De Moragas JM, Infantile eosinophilic pustular folliculitis, Dermatology 1994; 189(2):133-8.

  8. Fujiyama T y Tokura Y, Clinical and histopathological differential diagnosis of eosinophilic pustular folliculitis, Journal of Dermatology 2013; 40:419-23.

  9. Zeichner J, Acneiform eruptions in dermatology, Nueva York-Heidelberg- Dordrecht-Londres, Springer, 2014, pp. 59-64.

  10. Nakahigashi K, Doi H, Otsuka A, Hirabayashi T, Murakami M, Urade Y y Tanizaki H, pgd 2 induces eotaxin-3 via pparγ from sebocytes: a possible pathogenesis of eosinophilic pustular folliculitis, Journal of Allergy and Clinical Immunology 2012; 129(2):536-43.

  11. Achenbach R, Jorge M y Sánchez G, Foliculitis pustulosa eosinofílica (enfermedad de Ofuji), Revista Argentina de Dermatología 2007: 88.

  12. Ishiguro N, Shishido E, Okamoto R et al., Ofuji’s disease: a report on 20 patients with clinical and histopathologic analysis, J Am Acad Dermatol 2002; 46(6):827-33.

  13. Ishiguro N, Shishido E, Okamoto R, Igarashi Y, Yamada M y Kawashima M, Ofuji’s disease: a report on 20 patients with clinical and histopathologic analysis, J Am Acad Dermatol 2002; 46(6):827-33.

  14. Kabashima K, Sakurai T y Miyachi Y, Treatment of eosinophilic pustular folliculitis (Ofuji’s disease) with tacrolimus ointment, Br J Dermatol 2004; 151:949-50.

  15. Anjaneyan G, Manne S, Panicker V y Eapen M, Ofuji’s disease in an immunocompetent patient successfully treated with dapsone, Indian Dermatol Online J 2016; 7(5):399-401.

  16. Malanin G y Helander I, Eosinophilic pustular folliculitis (Ofuji’s disease): response to dapsone but not to isotretinoin therapy, J Am Acad Dermatol 1989:20.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Dermatología Cosmética, Médica y Quirúrgica. 2020;18